IRMD vs. SRTS
IRMD (IRadimed Corporation) and SRTS (Sensus Healthcare, Inc.) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 10 years, IRMD returned 18.50%/yr vs -7.48%/yr for SRTS. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
IRMD vs. SRTS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IRMD achieves a -5.48% return, which is significantly higher than SRTS's -26.63% return. Over the past 10 years, IRMD has outperformed SRTS with an annualized return of 18.50%, while SRTS has yielded a comparatively lower -7.48% annualized return.
IRMD
- 1D
- 0.77%
- 1M
- -9.32%
- 6M
- -7.12%
- YTD
- -5.48%
- 1Y
- 40.30%
- 3Y*
- 25.47%
- 5Y*
- 24.32%
- 10Y*
- 18.50%
- ALL TIME*
- 21.12%
SRTS
- 1D
- 0.34%
- 1M
- -4.89%
- 6M
- -42.86%
- YTD
- -26.63%
- 1Y
- -47.67%
- 3Y*
- -1.97%
- 5Y*
- -4.21%
- 10Y*
- -7.48%
- ALL TIME*
- -7.15%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $12.29M | $12.46M | $12.65M | |
| $59.83K | $62.18K | $174.61K |
IRMD vs. SRTS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IRMD IRadimed Corporation | -5.48% | 79.69% | 16.99% | 75.37% | -37.53% | 102.68% | -2.48% | -4.42% | 61.45% | 36.49% |
SRTS Sensus Healthcare, Inc. | -26.63% | -42.49% | 193.22% | -68.19% | 2.77% | 87.05% | 9.04% | -52.23% | 43.60% | -1.71% |
Correlation
The correlation between IRMD and SRTS is 0.19, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.19 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.18 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2016 | 0.13 |
Fundamentals
IRMD:
$1.17B
SRTS:
$48.07M
IRMD:
$1.79
SRTS:
-$0.47
IRMD:
13.65
SRTS:
2.12
IRMD:
11.58
SRTS:
1.06
IRMD:
$86.34M
SRTS:
$22.53M
IRMD:
$65.50M
SRTS:
$8.51M
IRMD:
$30.70M
SRTS:
-$8.57M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IRMD vs. SRTS — Risk / Return Rank
IRMD
SRTS
IRMD vs. SRTS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IRadimed Corporation (IRMD) and Sensus Healthcare, Inc. (SRTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IRMD | SRTS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.89 | ||
| Sortino ratioReturn per unit of downside risk | +2.50 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.90 | +0.33 |
| Calmar ratioReturn relative to maximum drawdown | 1.96 | -0.94 | +2.90 |
| Martin ratioReturn relative to average drawdown | 5.14 | -1.39 | +6.53 |
Loading charts...
Drawdowns
IRMD vs. SRTS - Drawdown Comparison
The maximum IRMD drawdown since its inception was -75.83%, smaller than the maximum SRTS drawdown of -87.51%. Use the drawdown chart below to compare losses from any high point for IRMD and SRTS.
Loading charts...
Drawdown Indicators
| IRMD | SRTS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.83% | -87.51% | +11.68% |
Max Drawdown (1Y)Largest decline over 1 year | -20.62% | -51.09% | +30.47% |
Max Drawdown (3Y)Largest decline over 3 years | -25.83% | -70.08% | +44.25% |
Max Drawdown (5Y)Largest decline over 5 years | -49.38% | -87.51% | +38.13% |
Max Drawdown (10Y)Largest decline over 10 years | -58.20% | -87.51% | +29.31% |
Current DrawdownCurrent decline from peak | -12.69% | -80.49% | +67.80% |
Average DrawdownAverage peak-to-trough decline | -27.83% | -47.13% | +19.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.86% | 35.27% | -27.41% |
Volatility
IRMD vs. SRTS - Volatility Comparison
IRadimed Corporation (IRMD) has a higher volatility of 11.04% compared to Sensus Healthcare, Inc. (SRTS) at 10.05%. This indicates that IRMD's price experiences larger fluctuations and is considered to be riskier than SRTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IRMD | SRTS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.04% | 10.05% | +0.99% |
Volatility (6M)Calculated over the trailing 6-month period | 23.94% | 48.58% | -24.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.64% | 73.47% | -40.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.85% | 81.55% | -38.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.22% | 73.22% | -25.00% |
Dividends
IRMD vs. SRTS - Dividend Comparison
IRMD's dividend yield for the trailing twelve months is around 1.35%, while SRTS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
IRMD IRadimed Corporation | 1.35% | 1.21% | 0.82% | 3.54% | 3.53% |
SRTS Sensus Healthcare, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
IRMD vs. SRTS - Financials Comparison
This section allows you to compare key financial metrics between IRadimed Corporation and Sensus Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IRMD and SRTS have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IRMD has higher volatility (11.04%) compared to SRTS (10.05%). In terms of maximum drawdown, IRMD dropped -75.83% vs SRTS's -87.51%.
IRMD currently has the higher Sharpe Ratio (1.24 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IRMD and SRTS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer